A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma Concentration

Inclusion Criteria: * Healthy as judged by the investigator/subinvestigator based on the results of physical examinations and laboratory tests * Body weight ; ≥50.0 kg, \<80.0 kg * Body Mass Index ; ≥17.6, \<26.4 kg/m2 * Written informed consent has been obtained Exclusion Criteria: * Received any investigational drugs within 120 days before the screening assessment * Donated 400 mL of whole blood within 90 days, 200 mL of whole blood within 30 days, or d components within 14 days before the screening assessment * Received medication within 7 days before hospital admission * A deviation from the assessment criteria of physical examinations or laboratory tests at screening or upon admission * History of drug allergies * With renal, hepatic, gastrointestinal, heart, cerebrovascular or respiratory diseases * Previous treatment with ASP1941